(Q60455157)
Statements
Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation (English)
Leighton Clancy
Renee Simms
Chun K K Ma
Jane Burgess
Shivashni Deo
Karen Byth
Ming-Celine Dubosq
22 February 2013